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Objective: The optimal timing for coronary artery bypass grafting after acute myocar-
dial infarction is not well established. The California Discharge Database facilitates
the study of this issue by providing data from a large patient cohort free of institutional
bias. We examine the timing of coronary artery bypass grafting after acute myocardial
infarction on short-term outcomes.
Methods:We reviewed California Discharge Data to identify 40,159 patients who were
hospitalized for acute myocardial infarction (day 0) and underwent subsequent coronary
artery bypass grafting. Patients were stratified by the timing of coronary artery bypass
grafting to ’’early’’ (days 0–2) and ’’late’’ groups (day 3 or later). The primary outcome
variablewas all-cause hospitalmortality.Multiple logistic and linear regression and pro-
pensity analyses assessed the risk of adverse events, controlling for factors associated
with preoperative clinical acuity, including the Charlson Comorbidity Index, shock,
mechanical ventilation, and the use of intra-aortic balloon counterpulsation.
Results: Of 9476 patients identified, 4676 (49%) were in the early coronary artery
bypass grafting group and 4800 (51%) were in the late coronary artery bypass grafting
group. A total of 444 patients (4.7%) died during hospitalization, with a peak mortal-
ity rate of 8.2% among patients undergoing coronary artery bypass grafting on day 0,
declining to a nadir of 3.0% among patients undergoing coronary artery bypass graft-
ing on day 3. The mean time to coronary artery bypass grafting was 3.2 days. Patients
undergoing early coronary artery bypass grafting experienced a higher mortality rate
than those undergoing late coronary artery bypass grafting (5.6% vs 3.8%, P, .001).
Early coronary artery bypass grafting was an independent predictor of mortality after
controlling for clinical acuity and on propensity analysis (odds ratio 1.43, P5 .003).
Conclusion: Patients undergoing coronary artery bypass grafting within 2 days of hos-
pitalization for acute myocardial infarction experienced higher mortality rates than
those undergoing coronary artery bypass grafting 3 or more days after acute myocar-
dial infarction, independently of clinical acuity. This suggests that coronary artery
bypass grafting may best be deferred for 3 or more days after admission for acute
myocardial infarction in nonurgent cases.
M
uch attention has focused on the outcomes of coronary artery bypass
grafting (CABG) in the setting of acute myocardial infarction (AMI).1-3 Al-
though it seems clear that patients who undergo CABG after AMI possess
a higher risk of short-term mortality compared with patients who undergo elective
CABG, the optimal timing of surgical revascularization remains controversial.1,4-6
Recent randomized controlled trials and meta-analyses performed in the setting of
AMI have convincingly demonstrated that primary percutaneous coronary interven-
tions (PCIs) yield superior results to thrombolytic therapy with decreased rates of
death, reinfarction, and stroke.7-9 Consequently, an increased number of patients
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ICD-9-CM 5 International Classification of Diseases,
Ninth Revision, Clinical Modification
OR 5 odds ratio
PCI 5 percutaneous coronary intervention
are receiving coronary angiography in the setting of
AMI.10,11 This, in turn, has led to an increase in identification
of candidates for surgical coronary revascularization (ie, in
the setting of failed angioplasty or left main/multivessel dis-
ease). With this focus on CABG in the context of AMI and
new trends in early management, the optimal timing of
CABG after AMI should be scrutinized.
Although no definitive recommendation exists regarding
the appropriate timing of CABG after recent AMI, the notion
that these patients assume greater risk for short-term mortal-
ity is gaining consensus.5,12-14 This is not surprising given
that the majority of patients who undergo early CABG pres-
ent with a higher degree of clinical acuity, which, in turn,
translates to higher mortality rates. For the stable patient
post-AMI for whom the culprit lesion has been effectively
treated with PCI, it is common practice to discharge the
patient to recover for some time before undergoing CABG
electively. Less certain, however, is the optimal management
of patients post-AMI who cannot be discharged from the
hospital before CABG because of a tenuous PCI result, dis-
ease severity, unstable angina, or compromised ventricular
function. The optimal timing for CABG in these patients
post-AMI was the focus of this study in which we performed
a retrospective review with multivariable and propensity-
based adjustments. We hypothesize that by controlling for
both clinical acuity and early surgical propensity, an optimal
time interval between AMI and CABG can be identified such
that early postoperative mortality is reduced.
Materials and Methods
Data Source
The State of California Office of Statewide Health Planning and
Development (Healthcare Quality and Analysis Division) provided
hospital discharge data for the years 1999 to 2005. The State of
California requires all licensed hospitals to submit data on all dis-
charged patients every 6 months. These records thus comprise
a 100% sampling of California nonfederal hospital discharges. All
data are de-identified and include demographic information, includ-
ing age, gender, race, information on primary and concomitant diag-
noses recorded and procedures performed, discharge information
(eg, disposition to skilled nursing facility, death), and administrative
information (eg, costs, payer information, length of stay, level of
care). Unlike many other databases, the California discharge504 The Journal of Thoracic and Cardiovascular Surgery c Madatabase discriminates between prior and new diagnoses with re-
spect to each hospital admission and identifies the dates of proce-
dures and operations performed. These features facilitated the
examination of outcomes related to the timing of CABG after
AMI. Because individual patients are not identified in this multicen-
ter registry report, the need for consent and institutional review
board approval is waived at The Johns HopkinsMedical Institutions.
Study Design
A retrospective review of California discharge data was performed
for the years 1999 to 2005. We identified all adult patients (.17
years of age) who were admitted to a California hospital with the pri-
mary diagnosis of AMI as identified by International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
diagnosis codes (410.x).15 We combined these patients with those
who underwent CABG of any type during their hospitalization
(also identified by ICD-9-CM procedure codes 36.x).
Patients were excluded if they had valvular pathology (ie, steno-
sis, insufficiency or active endocarditis of the mitral, aortic, pulmo-
nary, or tricuspid valves) or underwent any concomitant cardiac
surgical procedures such as mitral or aortic valve repair or replace-
ment, ventricular remodeling, or ventricular assist device placement.
In addition, patients were excluded if they presented with ’’do not
resuscitate’’ status on admission or if they were transferred from
another hospital (because we did not have information on the timing
of AMIs in these patients) (Table E1).
Creation of Variables
Variables crucial to the analysis not present in the data set were de-
rived using existing data set variables and known ICD-9-CM codes.
The primary derived variable was the timing of CABG after AMI.
The data set parameters yielded time intervals expressed in
’’days’’ rather than finer time intervals of hours or minutes. In this
analysis, we designated day 0 as the initial day of hospital admis-
sion. Baseline independent variables describing medical status and
outcome variables (other than death) were developed from ICD-
9-CM coding and are subsequently listed in Table E2. We used
the Charlson scoring system16 with Deyo adaptation17 as a standard-
ized index reflecting the overall burden of comorbidities in the study
population. Our primary outcome variable was all-cause in-hospital
mortality.
Patient Groups
Because of the lack of standardized timing intervals for the perfor-
mance of CABG after AMI, we grouped patients into ’’early’’ and
’’late’’ groups on the basis of the median time to CABG for our study
population (day 3). Early CABG was thus defined as CABG per-
formed on hospitalization day 0, 1, or 2, and late CABGwas defined
as CABG occurring on or after day 3. We also examined differences
in outcomes dichotomized between other time points such as day
0 versus day 1 and after, day 0 and 1 versus day 2 and after, and
so forth.
Statistical Analysis
Comparisons of baseline characteristics between study groups were
performed using the Student t test for continuous variables and the
chi-square test for categoric variables. Mortality was first assessed
for all risk factors using a univariate model. Significant predictors
of mortality (both chronic and acute) were incorporated intorch 2008
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sess the effect of timing of CABG on mortality. Operative timing
and mortality were plotted for all time points present to determine
whether an optimal time for the performance of CABG after AMI
exists.
To assess selection bias not controlled for in our multivariate
model and to counter the censoring that occurs from early mortality,
we used a propensity-adjustment model. We developed propensity
scores (based on the likelihood of receiving early CABG on days
0, 1, or 2) derived from a logistic regression model incorporating
35 potential predictors of operative timing (Table E3). We incorpo-
rated the resultant propensity scores into a logistic regression model
to negate selection bias in examining the effect of propensity for
early CABG on in-hospital mortality. We also used quintile stratifi-
cation for both internal validation of our technique and examination
of the effects of timing in different subsets of propensity.
All odds ratios (ORs) are presented with 95% confidence inter-
vals. All statistical analysis was performed with the aid of STATA
software (version 9.0, StataCorp LP, College Station, Tex).
Results
Between 1999 and 2005, California hospitals recorded a total
of 443,069 patient discharges with the primary diagnosis of
AMI. Of these patients, 40,159 underwent CABG during
their hospitalization. After exclusion of children (,18 years
of age), hospital transfers, patients with concomitant cardiac
procedures, and patients with incomplete data, 9476 patients
were included in the final study population.
We noted that 75% of CABG (n5 7086) procedures were
performed during the first 5 days of hospitalization (Figure 1).
The median time to CABG was 3 days (mean 3.26 3.0). By
stratifying according to this median, 4676 patients (49%)
were classified as the early CABG group (CABG performed
on days 0, 1, or 2) and 4800 patients were classified as the late
group (CABG performed on day 3 or later). The early group
consisted of a lower percentage of female patients compared
with the late group (28% vs 33%, P, .001). Both groups hadThe Journal of Thosimilar baseline comorbidities with mean Charlson scores of
5.2 and 5.8, respectively (P , .001) (Table 1). As expected,
patients in the early CABG group were of higher acuity with
greater proportions presenting with shock and requiring in-
tra-aortic balloon pump (IABP) counterpulsation. Of note,
the early group had a lower percentage of subendocardial
infarcts (45% vs 61%, P , .001).
In-hospital mortality for the entire study period was 4.7%
(444 patients). Patients undergoing CABG on their initial day
of admission had an 8.2%mortality rate. Plotting of mortality
over time revealed a nadir for patients undergoing CABG on
hospital day 3 with a mortality rate of 3.0% (Figure 1). This
low mortality rate persisted for those receiving CABG on
days 4 and 5 but increased thereafter. Patients who underwent
CABG between days 14 and 28 experienced a 12.5% in-hos-
pital mortality rate (P, .01). The greatest decline in mortal-
ity in a 1-day period occurred for patients undergoing CABG
on the first hospital day. A 3.7% decline in mortality (P ,
.05) was observed when CABG was performed on hospital
day 1 compared with the day of admission.
Univariate analysis revealed early CABG to be highly
associated with an increased risk of mortality (5.6% vs
3.8%, P , .001). This positive association was confirmed
with multivariable logistic regression analysis controlling
for gender, baseline comorbidities as assessed by the Charl-
son index, and markers of clinical acuity, including IABP,
shock, cardiac arrest on admission, and ventilation before
CABG (Table 2). The OR of 1.43 corresponds to a 43% in-
crease in the risk of death among patients who underwent
early CABG, controlling for the aforementioned markers of
clinical acuity. Other strong predictors of death included
IABP, shock on admission, cardiac arrest on admission,
female gender, and Charlson index.
After we controlled for the propensity to undergo early
surgery (C-index 0.76), CABG performed before day 3 con-
tinued to be positively associated with mortality risk (ORFigure 1. CABG volume and mortality
over time. Distribution of CABG volume
(left Y-axis, number of cases per day)
and percent mortality (right Y-axis) per
day of hospitalization. Dashed horizon-
tal line represents total mortality over
the study period (4.8%). Black arrow
points to nadir of mortality occurring
on day 3. CABG, Coronary artery bypass
graft.racic and Cardiovascular Surgery c Volume 135, Number 3 505
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with early CABG (mean score 0.61 vs 0.37, P , .001) con-
firming that they did, in fact, predict early surgery. When
stratified into propensity quintiles, only the lowest propensity
group retained this positive association. Therefore, those pa-
tients with the least need to undergo early CABG had a 2-fold
risk of death if they underwent early CABG (OR 1.58, P 5
.03). By performing serial propensity-adjusted analyses for
all combinations of early and late CABG, we found that the
relationship between early CABG and increased mortality
ceased on hospital day 4 (OR for death if CABG performed
on days 0–3 vs $ 4, 0.92, P 5 .45). Thus, hospital day 3
seemed to be the cutoff point whereby further delay to
CABG did not improve survival.
To determine optimal operative timing in patients with
AMI presenting with high clinical acuity, we examined those
patients with transmural infarctions (ie, acute infarctions not
coded as ’’subendocardial’’) who were classified as having
shock or who underwent IABP placement. Among these pa-
tients, we noted that the lowest mortality rates were observed
when CABG was performed on hospital day 3 (Figure 2). As
for the entire study population, mortality rates increased after
day 4 among patients in this high-acuity group. The overall
TABLE 1. Baseline demographics and acuity between early
and late coronary artery bypass graft groups
Early CABG
N 5 4676
Late CABG
N 5 4800
P
value*
N (%) or mean (SD)
Mean age (SD) 66.6 (11) 68.6 (11) ,.001
Female (%) 1306 (28) 1566 (33) ,.001
Black, Hispanic, Native
American, Asian/Pacific
Islander 6
930 (20) 1312 (27) ,.001
Obesity 623 (13) 602 (13) .26
Charlson index (SD) 5.2 (1.8) 5.8 (1.9) ,.001
Subendocardial infarct 2114 (45) 2927 (61) ,.001
Cardiac arrest on
admission
65 (1) 78 (2) .35
Shock 314 (7) 166 (3.4) ,.001
IABP before CABG 469 (10) 412 (8.6) .02
V-Fib on admission 81 (1.8) 91 (1.9) .78
A-Fib on admission 570 (12) 774 (16) ,.001
Angiogram before CABG 4213 (90) 4592 (96) ,.001
Coronary stent
before CABG
493 (11) 457 (10) .1
Bypass (4 vessels) 1261 (27) 1245 (26) .26
Bypass (3 vessels) 1552 (33) 1711 (36) .01
Bypass (2 vessels) 1319 (28) 1288 (27) .13
Bypass (1 vessels) 452 (10) 435(9) .31
CABG, Coronary artery bypass graft; SD, standard deviation; IABP, intra-
aortic balloon pump; V-Fib, ventricular fibrillation; A-Fib, atrial fibrillation.
*P value is based on comparison between 2 groups by either chi-square
or Student t test. 6 Race or ethnic group was a variable present in the
data set.506 The Journal of Thoracic and Cardiovascular Surgery c Main-hospital mortality rates for patients presenting with shock
and IABP placement were 24% (90/480 patients) and 7%
(65/881 patients), respectively.
Discussion
Although the debate regarding the optimal timing of CABG
after AMI is not yet settled, the findings of this study lend
support to an increasing body of medical literature demon-
strating increased risks of urgent surgical coronary revascu-
larization in the setting of AMI. As in many issues in
cardiac surgery, this topic has undergone evolution as tech-
nology has improved and mortality rates for CABG have de-
clined. Studies conducted in the early 1980s by DeWood and
colleagues18,19 focusing on this question showed a benefit to
performing early CABG. Although valid at the time, these
studies were conducted in an era before the widespread insti-
tution of PCI and thrombolysis in the setting of AMI.
More recently, retrospective examinations have con-
cluded that CABG should be deferred, when possible, for 3
or more days after AMI.12,13,20 Lee and colleagues13,20
have conducted several studies describing the appropriate
timing of CABG after AMI. By using the state of New
TABLE 2. Risk factors for mortality determined from
multivariable logistic regression analysis
Risk factor
OR
(95% CI)
P
value*
Multivariable analysis without propensity adjustment
Day of CABG (across entire study period) 0.99 (0.95–1.02) .65
Early CABG (days 0–2) 1.43 (1.12–1.18) .003
Female gender 1.46 (1.16–1.85) .002
Charlson index 1.29 (1.20–1.39) ,.001
Shock 3.58 (2.41–5.32) ,.001
Cardiac arrest on admission 3.23 (1.59–6.54) ,.001
IABP before CABG 1.51 (1.09–2.1) .01
Ventilated before CABG 1.25 (0.79–1.98) .32
V-Fib on admission 1.03 (0.45–2.23) .98
Anterolateral infarct 1.08 (0.47–2.29) .93
Multivariable analysis with propensity adjustment
Early CABG (days 0–2) 1.40 (1.12–1.74) .003
Propensity score 1.32 (0.87–2.01) .18
Risk of death with early CABG as stratified by propensity quintile
Quintile 1 (Pscore 0.03–0.32) 1.58 (1.05–2.34) .03
Quintile 2 (Pscore 0.32–0.36) 1.21 (0.75–1.94) .43
Quintile 3 (Pscore 0.39–0.46) 1.46 (0.83–2.58) .19
Quintile 4 (Pscore 0.46–0.60) 1.39 (0.77–2.5) .28
Quintile 5 (Pscore 0.60–0.90) 3.80 (0.42–34.3) .23
OR, Odds ratio; CI, confidence interval; CABG, coronary artery bypass graft;
V-Fib, ventricular fibrillation; IABP, intra-aortic balloon pump; Pscore,
propensity score. This analysis was performed with and without propensity
adjustment and with quintile propensity stratification. *P value is based on
multivariable logistic regression analysis, using all factors significant on
univariate analysis.rch 2008
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CABG. Percent mortality for those patients with
transmural AMI (defined as acute infarctions not
coded as ''subendocardial'') and shock (light
grey bars) or IABP placement preoperatively
(dark grey bars). Note that for both patient sets,
the nadir of mortality occurs on hospital day 3.
Total patient numbers for each day (n) are given
below each bar. IABP, Intra-aortic balloon pump;
CABG, coronary artery bypass graft.York database, the authors showed that the risk of early
CABG is substantially higher before hospital day 3, with
a doubling of mortality risk compared with patients who un-
derwent later surgery. This positive association between
early CABG and mortality was seen to be particularly impor-
tant for transmural infarcts. Another study by Voisine and as-
sociates12 concluded that CABG is best deferred for a period
of 7 days after AMI. One should note, however, that this
study examined only 77 subjects from a single institution
(1991–2005) who underwent CABG within 24 hours of
admission.
Although these prior studies are valuable in supporting the
notion that delayed CABG is preferable under elective clini-
cally stable circumstances, they have not specifically ad-
dressed patients with AMI presenting with higher clinical
acuity. Kamohara and colleagues14 attempted to examine
this issue by focusing on patients who underwent urgent
CABG only. In their report, they conclude that patients
who underwent early CABG (ie, within 6 hours of AMI) ex-
perienced higher mortality rates (9.1% vs 2.9%) than those
who underwent CABG later in their course (ie, 6–24 hours
after AMI). Although this study attempted to examine the ef-
fect of timing among acutely ill patients, it is a single-center
report that did not include patients undergoing CABG 24 or
more hours after AMI. It is possible that outcomes would
have improved among these patients if CABG had been
further delayed.
In our analysis, we attempted to bridge this gap in knowl-
edge by focusing on hospitalized patients, identifying a mod-
ern cohort of patients among multiple centers who presented
with higher clinical acuity than those reported in prior studies
but did not require urgent CABG. We used this strategy to
determine the optimal timing of surgery among patients
with AMIwho underwent CABG during their initial hospital-
ization.
Our study uniquely possesses an even distribution of post-
AMI CABG timing intervals. With 1477 patients undergoing
CABG on their initial hospital day, early CABG was wellThe Journal of Thorrepresented in this sample. The fact that we only examined
patients who required hospital admission may partially
explain why the in-hospital mortality rate of 4.8% may be
higher than previously reported mortality rates, typically
ranging from 2.3% to 3.3%.12,20
This study is also distinguished by the robust statistical
methods we used to control bias inherent in its retrospective
design. We addressed 2 important statistical problems. First,
patients who underwent early CABG inherently assumed
a greater mortality risk associated with their increased level
of acuity, constituting a selection bias. Although traditional
multivariate models can attempt to limit this risk, an obvious
flaw is the difficulty of accounting for all potential con-
founders. Second, patients who underwent early CABG and
died are excluded from being a part of the late CABG group.
This effect, termed censoring, leads to relative inequality be-
tween the 2 groups and violates a fundamental assumption of
multivariate models. Because those patients who die cannot
be part of the late group, a bias that inflates late group survival
occurs. In the absence of a gold standard blinded, randomized
controlled trial, these effects are difficult to control.
We attempted to address these statistical concerns by
using a propensity-adjusted analysis. The use of propensity
scores represents another tool to help eliminate bias in a retro-
spective study and has been used successfully in other land-
mark surgical studies.21-23 The propensity score (ranging
from 0–100) predicts which patients are likely to receive
a treatment or, in this case, early CABG. Propensity scores
are particularly useful when the primary outcome is rare. Un-
like traditional multivariate analyses, the propensity-based
approach addresses the issues of selection bias and censoring
by adjusting for the likelihood of receiving early CABG, not
simply by adjusting for known confounders. We think that
the use of a propensity-based approach is an effective way
to address the issue of timing in this analysis.
By using propensity-adjusted analysis, the findings of this
study are consistent with previous reports showing that early
CABG (before day 3) is associated with an increased risk ofacic and Cardiovascular Surgery c Volume 135, Number 3 507
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among those patients who underwent CABG before day 3
(5.6% vs 2.8%). This effect was independent of factors asso-
ciated with acuity and propensity-based analysis. It is note-
worthy that on quintile assessment, the effect seemed to be
restricted to the lowest propensity quintile. In other words,
those patients with low likelihood for undergoing early
CABG derived the worst effect from receiving early
CABG. These results suggest that early elective CABG in
the setting of AMI is associated with a heightened postoper-
ative mortality risk that might otherwise be ameliorated by
deferring the operation. Our analysis suggests that 3 to 5
days seems to be an optimal timing window for performing
an elective CABG after AMI.
An unexpected observation from this study showed that
postoperative mortality rates trended upward after day 5. In
fact, patients who underwent CABG between days 14 and
28 experienced a 12.5% risk of mortality. In contrast, previ-
ous studies have noted a steady downward trend in mortality
with increasing time after AMI. In our cohort, among patients
who underwent CABG after day 14, 16% presented in shock
(n 5 7), 29% required mechanical ventilation (n 5 13), and
20% required IABP placement (n5 9) preoperatively. Thus,
it is likely that our findings are reflective of sicker patients
who required extended hospitalization after an AMI.
We also examined a critically ill population by examining
only those patients with a transmural infarction who pre-
sented in hemodynamic shock or who underwent IABP
placement. It is noteworthy that these patients also derived
mortality benefit from waiting until day 3 to perform
CABG but experienced increased mortality if CABG was
performed after day 4. These findings support that, even in
the setting of high-acuity patients, survival benefit may be
derived from deferring CABG 2 to 3 days after AMI.
Use of the California Database
We chose to use the California statewide database in this
analysis because of 2 key features. The first was the ability
to gauge procedural timing, which was crucial to the analysis.
The second was the discrimination between diagnoses pres-
ent on admission to the hospital versus new diagnoses
made during the hospitalization. This allowed us to deter-
mine whether a patient characteristic was preexistent or
developed subsequent to CABG. For the purposes of retro-
spective analyses, a large database provides a large sample
size that is free of institutional bias. Because individual insti-
tutional practices with respect to performing CABG after
AMI differ dramatically, we think that this freedom from
institutional bias gives our study added power.
Study Limitations
We recognize that there are several limitations in our study.
First, our study is retrospective and cannot account for in-
herent undocumented differences in patient characteristics.508 The Journal of Thoracic and Cardiovascular Surgery c MaAlthough we attempted to control for selection bias with pro-
pensity and multivariate statistical methods, we concede that
a fundamental problem of any retrospective study examining
interventional timing is the inherent heightened acuity of pa-
tients who undergo early CABG. Second, we were reliant on
the variables provided by the California discharge database.
Several markers of clinical acuity (eg, left ventricular ejection
fraction) were not available and thus could not be included.
Finally, administrative databases, including the one we
used, and studies based on them are reliant on accurate cod-
ing. We acknowledge that the data presented here were not
necessarily entered by individuals with clinical expertise.
Subtle differences in coding definitions may exist between
different institutions; neither the coding nor procedural tim-
ing included in the California discharge data has been vali-
dated for patients undergoing CABG. However, although
errors and variance in the data undoubtedly exist, we have
assumed that these are randomly distributed and should not
lead to significant bias in our conclusions. Without a random-
ized controlled clinical trial, we thought that a retrospective
study with compensatory statistical methods constituted a
reasonable approach to address this issue.
Why Delayed CABG May Be Preferable
In light of the present findings and similar conclusions by
others, we must ask the question of why delayed CABG leads
to improved outcomes in the setting of AMI. Intuitively it
seems that early reperfusion would lead to the preservation
of myocardium, thus limiting infarct size. However, reperfu-
sion injury can lead to increased damage to the vital myocar-
dium beyond the ischemic insult.24 Furthermore, it is known
that during the acute phases of an infarct, whole body inflam-
matory states are increased with increased levels of C-reac-
tive protein as a marker.25,26 It is possible that reperfusion-
induced inflammatory states have systemic manifestations
that increase mortality. Beyond biological explanations, on
a programmatic level, it is also possible that outcomes are
improved by operating in a planned and controlled setting
where routine physician, nursing, and ancillary staff are pres-
ent and rested. Whether these or other unknown factors con-
tribute to reduced mortality by deferring CABG after AMI is
still unclear and a subject of considerable interest.
Conclusions
In this analysis, we sought to determine the optimal CABG
timing after AMI among patients who underwent surgery
during the index hospitalization. We observed a reduced
mortality rate when CABG was deferred until hospital day
3, consistent with previous reports. This effect was also
observed among high-acuity patients who presented in hemo-
dynamic shock or requiring IABP support. These results sug-
gest that CABGmay best be deferred for 3 or more days after
admission for AMI under nonurgent clinical circumstances.rch 2008
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Discussion
Dr Mitruka (Rancho Mirage, Calif). I think there is little question
that early revascularization confers a survival advantage in patients
with AMI. This has been demonstrated by the cardiologists perform-
ing PCI in this patient population. Indeed, the door to balloon time is
now a benchmark for programmatic success. This early intervention
has resulted, however, in many surgeons being cajoled or even co-
erced into performing high-risk operations earlier than may be ben-
eficial. The optimal timing of surgical revascularization after AMI
remains somewhat controversial, although it is generally accepted
that waiting is better. This was demonstrated by the Columbia group
evaluating New York State databases, and they showed that waiting
to operate, especially in patients with transmural infarcts, results in
better outcomes.
This retrospective study performed by the Johns Hopkins group
using California discharge data adds to the growing body of litera-
ture that attempts to objectify the optimal timing of CABG after
AMI. This group is to be congratulated for a statistical tour de force
that overcame many of the inherent limitations and biases of a retro-
spective study in drawing meaningful conclusions. By using multi-
ple logistic and linear regression, as well as propensity-adjusted
multivariate analysis, the risk of adverse events could be assessed
while controlling for factors associated with high preoperative clin-
ical acuity. With this methodology, they were able to conclude that
early CABG less than 3 days after an AMI was an independent pre-
dictor of mortality after controlling for clinical acuity and surgical
propensity. Identifying the optimal timing of CABG after AMI to
be 3 to 5 days to reduce postoperative mortality will be of clear clin-
ical benefit. Furthermore, outlining that patients with higher acuity
undergoing operation sooner will have higher morbidity will be
beneficial in aligning outcome expectations between surgeons and
our referring physicians. With that long-winded preamble, I have
a few questions that you are invited to answer individually.
It is generally well accepted by most surgeons that preoperative
assessment of left ventricular function, particularly after an AMI,
is one of the best predictors of postoperative outcome. Yet, leftracic and Cardiovascular Surgery c Volume 135, Number 3 509
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assessed. Could you comment as to why?
DrWeiss. I agree with you that left ventricular function is impor-
tant. The reason we were not able to include it was because it was
simply not a component of the California discharge database.
Clearly these administrative databases have limitations, the princi-
ple one being a limitation of the data and variables that would be
present if you had an opportunity to design the study from the begin-
ning and oversee data collection. If we had control of the data set, we
certainly would be interested in examining ventricular function. In
addition, there is selection bias associated with retrospective admin-
istrative databases and an inability to recognize undocumented
inherent patient differences.
Rather than focusing on the weaknesses of these studies, I like to
focus on the strengths, being that these types of studies provide
a broad multi-institutional sample. They allow examination of out-
comes that are applicable to both small centers and large academic
institutions. They offer another tool for providing evidence-based
guidelines for our patients. I think the best way to address variables
that are not present in the data set is to conduct a secondary study,
perhaps using institutional data where you can control what vari-
ables are present. In fact, we are in the process of conducting a sim-
ilar study based on our own institutional data with patients
undergoing CABG, and we hope that this will provide some of
the answers that are not readily available using the California data-
base.
Dr Mitruka. The anatomic location and size of the infarct are
allegedly addressed by the comorbidity index, the Charlson index.
However, it is also well recognized that patients with transmural in-
farcts that are perhaps anterior infarcts pose a higher risk in the peri-
operative period when operated on sooner rather than later. Was
there any way to distinguish those patients in this database during
your analysis to come up with a subgroup of patients who perhaps
were at even higher risk?
Dr Weiss. We could identify the location of the infarct on the
basis of the data we had. We incorporated that information into
our propensity adjustment. On the multivariable logistic
regression, we only used anterolateral infarct because that was the
only factor that was a significant predictor of mortality on univariate
analysis. So the answer to your question is yes, we did look at those
variables. We incorporated them in a univariate model, and then we
used them in our multivariable model accordingly.
DrMitruka.We, as clinical surgeons, oftentimes feel as though
the longer we can wait, or we are taught to believe that the longer we
can wait after an AMI before operating, the better, so I was a bit sur-
prised to see that the longer you waited with patients, 2 to 3 weeks
after an MI, the higher the mortality. We would have expected that
the mortality decreases over the course of time. Would you com-
ment on that?
Dr Weiss. As you pointed out, according to the studies done by
the Columbia group, you would expect mortality to decrease over
time. That has been shown in the past, and our findings would
seem to contradict their findings. I think the difference lies in the
fact that we looked at a subset of patients who were hospitalized
and could not be discharged. Previous studies looked at patients
who could be discharged. We thus examined a more acute cohort
of patients, and I speculate that the reason some of these patients
had higher mortality was because those who underwent operation510 The Journal of Thoracic and Cardiovascular Surgery c Malater possessed higher clinical acuity with more comorbidities.
This is perhaps the type of patient who has brittle diabetes, conges-
tive heart failure, or COPD. This is the type of patient who you
would prefer not to operate on, but for one reason or another later
on in their hospitalization your hand is forced. We do have data to
back that up. We examined that subset of patients, the late patients,
and we did see that their Charlson Index was a full point higher than
that of the remainder of the study population, so they indeed had
a higher comorbidity index. In addition, those patients had a higher
percentage of shock, higher percentage of intraaortic balloon pump,
so I suspect that the difference is that our patient population is
slightly different and that those patients operated on later were
more acutely ill.
Member of the audience: I just want to ask one quick question.
Did you look at the mortality rate for AMI without surgery? Is this
an effect that occurs because the highest death rate from AMI is
early, and this is an effect maybe of the disease rather than surgery?
Dr Weiss. That is a good point. We did not specifically do the
same analysis on AMI without surgery. We designed the study to
capture data such that we only looked at those who received surgery.
I agree with you, and I think it is probably true that this is a function
of the disease process, but within that disease process, if we look at
the subset of those who have required surgery, we should still be
able to identify the optimal time for CABG surgery in that cohort.
Dr Vallieres (Seattle, Wash). I am not a cardiac surgeon but I
was wondering if you had looked at which day of the week (eg,
Monday, Tuesday) when the infarct occurred and correlated to the
day of the week when the revascularization occurred and whether
this had an impact on these variables.
Dr Weiss.We did not. It was not present in the data set, and we
did not look at it.
Dr Cohen. I had a couple of questions, but as the discussion en-
sued they turned into comments. The first comment is that I have to
take issue with the statement that there are patients early on who
would have fared better had you waited to operate. I think the study
of your design might have been better had you excluded some of the
patients who were absolutely without question going to die early
without operation because I think they would have died had you
waited, and so I think that invalidates that statement.
The second thing is that I have to emphasize what our primary
discussant said. I think that ventricular function in the face of
AMI and in determining when that patient is going to undergo op-
eration is absolutely crucial, and I think that might be the fatal
blow in determining the validity of this study because this study is
incredibly important. Heart surgeons are going to rely on studies
such as this in determining how to make life and death decisions
for patients. I just don’t know how you can do it without knowing
what the ventricular function is in the face of an AMI.
DrWeiss.As I said, we are attempting to perform a second study
using our own institutional data that may answer some of those
questions.
Dr Slater (Portland, Ore). I have some quick data questions.
Did you segregate the data for men and women? Is the day of hos-
pitalization the same as the day of MI for your group or was there
any variability in that some patients come in several days after their
MI? You have the date of surgery, but did you break it down by pa-
tients who came in, had an AMI on sayMonday, Tuesday, are cathe-
terized, and you are operating Tuesday night, versus patients whorch 2008
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CDare catheterized and scheduled for surgery the following day, and
they are done as an elective case?
Dr Weiss. We did not segregate on the basis of gender. We did
look at gender in our multivariable model. Female gender was a pre-
dictor of worse outcomes, as has been shown previously.
The structure of the database does not really allow us to discrim-
inate based on the hours at which you receive your CABG. It is only
based on days. It is one of the limitations of the study, and we
acknowledge that.The Journal of ThorTo answer your question about which patients presented and
when they presented, these were all patients whose hospital day
zero was their initial day of hospitalization, and it was also their
day of presentation, the day that they had an AMI. We went to
great efforts to identify patients who were admitted to the hospital
solely with the principle diagnosis of AMI. For example, we
excluded hospital transfers. We wanted to identify a group of
patients for whom day zero truly was the day that they were
admitted with AMI.acic and Cardiovascular Surgery c Volume 135, Number 3 511
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Exclusion criteria ICD-9-CM codes
No. of patients excluded
(original N 5 40,159)
Age , 18 y NA 1
Hospital transfers NA 15,276
Incomplete data, including no data on CABG timing available NA 13,261
Diseases of mitral valve (stenosis and insufficiency) 394, 394.0, 394.1, 394.2, 394.9, 424.0 1108
Additional cardiac pathology
Diseases of aortic valve (stenosis and insufficiency) 395, 395.0, 395.1, 395.2, 395.9, 424.1, 746.5, 746.6 439
Combination mitral and aortic disease 396, 396.0, 396.2, 396.3, 396.8, 396.9, 746.3, 746.4 184
Pulmonary valve disease 397.1, 424.3, 746.00, 746.01, 746.02, 746.09 2
Tricuspid valve disease 397, 397.0, 424.2, 746.1 69
Malfunctioning mechanical valve 996.02, 996.71 1
Concomitant procedures
Mitral valve replacement/repair 35.1, 35.12, 35.2, 35.23, 35.24, 35.33, 35.98, 35.99 15
Aortic valve replacement/repair 35.01, 35.11, 35.21, 35.22 11
Heart transplantation 37.5, 37.51 0
Implantation of removal of ventricular assist device 37.64, 37.65, 37.66 318
Pulmonary valve replacement/repair 35.03, 35.13 0
Tricuspid valve replacement/repair 35.04, 35.14 0
Final study population 9476
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; NA, not available.511.e1 The Journal of Thoracic and Cardiovascular Surgery c March 2008
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Primary variable day of CABG
Baseline
Independent variables ICD-9-CM codes used
Charlson index* See below
Diabetes mellitus (Y/N) 250, 250.0 250.1, 250.3, 250.7, 250.8, 250.9
COPD 491.2, 491.20, 491.21, 491.22 492, 492.0, 492.8
Hypertension 401, 401.1, 401.91
CRF 585, 588
History of stroke 431, 433, 433.3, 433.8, 433.9, 434, 434.0, 434.1, 434.9
Hyperlipidemia 272.2, 272.4
Obesity 278.0, 278.00, 278.01
PVD 443, 443.8, 443.89, 443.9
Type of AMI:
Anterolateral 410, 410.0, 410.00, 410.01, 410.02, 410.1 410.10, 410.11, 410.12
Posterior 410.6, 410.60, 410.61, 410.62
Inferior 410.4, 410.40, 410.41, 410.42
Lateral 410.5, 410.50, 410.51, 410.52
Subendocardial 410.7, 410.70, 410.71, 410.72
Acuity variables ICD-CM (for procedures) codes
CPR 99.63
IABP before CABG 376.1
Conduction disorder on admission 426, 426.0, 426.1, 426.10, 426.11, 426.12, 426.13, 426.2, 426.3, 426.4,
426.5, 426.50, 426.51, 426.52, 426.53, 426.54, 426.6, 426.8, 426.81,
426.89, 426.9
Ventricular fibrillation on admission 427.4, 427.41, 427.42
Cardiac arrest on admission 427.5, 779.85
Mechanical ventilation before CABG 967, 967.0, 967.1, 967.2, 960.4
Shock 785.51
Atrial fibrillation on admission 427.3, 427.31, 427.32
Ventricular tachycardia on admission 427.1
Coronary stent before CABG 00.45, 00.46, 00.47, 00.48, 00.66, 36.01 36.02, 36.05, 36.06, 36.07
Angiogram before CABG 88.5, 88.50, 88.51, 88.52, 88.53, 88.54, 88.55, 88.56, 88.57
Outcome variables
Postoperative LOS Present in database
Postoperative stroke 431, 433, 433.3, 433.8, 433.9, 434, 434.0, 434.1, 434.9
Prolonged ventilation (.96 h) 967.2
Postoperative ARF 584, 584.6, 584.7, 584.8, 584.9, 586
587, 588, 5880, 588.1, 588.8, 588.9
Postoperative new onset dialysis 125.5, 389.5, 392.7, 394.2, 399.5
Wound infection 998.5, 998.59
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; CABG, coronary artery bypass graft; AMI, acute myocardial infarc-
tion; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; CRF, chronic renal failure; ARF, acute renal failure; CPR, cardiopulmo-
nary resuscitation; IABP, intra-aortic balloon pump; LOS, length of stay. *Charlson Index includes a weighted compilation of 17 baseline comorbidities in
multiple systems, including cardiovascular (ischemic disease and congestive heart failure), renal, endocrine (diabetesmellitus), cerebrovascular, peptic ulcer,
rheumatologic, hepatic, oncologic (history of cancer or malignancies), and infectious (human immunodeficiency virus/acquired immune deficiency). A total of
1186 unique ICD-9 codes are used for the creation of the Charlson Index.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 3 511.e2
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CDTABLE E3. Variables included in propensity analysis to
assess the likelihood of undergoing early coronary artery
bypass grafting
Category Variable
Demographics Age (y)
Gender
Race
Charlson index score*
Hypertension (not part of Charlson)
MI type Anterolateral infarct
Subendocardial infarct
Acuity Shock
Cardiac arrest on admission
Thrombolysis before CABG
Mechanical ventilation before CABG
Conduction disorder
Ventricular fibrillation on admission
Ventricular tachycardia on admission
Atrial fibrillation on admission
Angina on admission
Red blood cell transfusion before CABG
Angiogram before CABG
Coronary stent before CABG
MI, Myocardial infarction; CABG, coronary artery bypass grafting. *These
variables include 17 Charlson index parameters to comprise the 35 variables
used to create the propensity score.511.e3 The Journal of Thoracic and Cardiovascular Surgery c March 2008
